Pharmafile Logo
Pharmafocus logo
Advanced Search

WikiLeaks

Showing 2 posts of 2 posts found.

Pfizer: WikiLeaks claims “preposterous”

December 10, 2010
Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …

News

WikiLeaks defends decision to publish critical facilities list

December 7, 2010
Manufacturing and Production WikiLeaks, pharma manufacturing, security

Pharmaceutical facilities have featured prominently in in the latest batch of secret US embassy cables made public by WikiLeaks. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025